Humanwell Healthcare | Briefing, News, Analysis, Research, Data

Humanwell Healthcare

Humanwell Healthcare insists on R&D as the guide

Humanwell Healthcare insists on R&D as the guide, and is at the forefront of R&D investment and new drug R&D progress among domestic pharmaceutical enterprises, and is committed to building a first-class platform for R&D and industrialization of new drugs in China.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Founded

Mar 30, 1993

HQ location

Hubei, China

Legal name

Humanwell Healthcare (Group) Co., Ltd.

Website

http://www.renfu.com.cn/

renfu.pr@renfu.com.cn

Employees

10001-50000

All
News
Analysis
Research

Briefing Apr 25, 2022 04:05 PM · Technology | Consumer Staples | Healthcare

Nissan announced the progress of assisted driving technology, which can detect the deceleration traffic flow

Briefing Mar 10, 2022 03:59 PM · Technology | Consumer Staples | Healthcare

Meierya: elect Zheng Jiping as chairman and Duan Wenyan as general manager

In-depth

Healthcare

Chinese Company Turned the Tables on Domestic Cell Culture Media Market

In this article, EqualOcean mainly introduce the history, competition, lead company, future trend in domestic cell culture media industry.

Feb 02, 2023 10:45 AM

Briefing Mar 09, 2022 04:49 PM · Technology | Consumer Staples | Consumer Discretionary

Beijing: it is preliminarily believed that the source of infection of infected person 2 notified on the 8th is from other provinces

Briefing Feb 22, 2022 05:09 PM · Healthcare | Financials | Automotive

Dorui pharmaceutical: clinical approval documents for subsidiaries to purchase new drugs

Research

Healthcare

Digital Therapeutics - Revolution of the healthcare system

Nov 16, 2022 05:19 PM

Research

Healthcare

2022 China AI Health 30 Report

Nov 07, 2022 04:27 PM

Research

Healthcare

2022 China’s Healthcare Industry: An Introductory Handbook

Aug 29, 2022 05:45 PM

Research

Technology, Healthcare, Financials

WIA2020 | 30 Tech Entrepreneurs in China

Apr 22, 2021 03:11 PM

Briefing Feb 14, 2022 05:00 PM · Financials | Automotive | Technology

Optical cable: it is proposed to set up Jiangsu Tong Optoelectronics Technology, which is mainly engaged in raw material trade

Briefing Jan 21, 2022 06:09 PM · Technology | Healthcare

Zhangyu A: Sun Jian, director and general manager, increased 30000 B shares on January 21

Briefing Jan 05, 2022 03:49 PM · Technology | Consumer Staples | Healthcare

China Merchants Steamship: Directors and senior executives plan to reduce their total holdings of no more than 904200 shares

Briefing Jan 04, 2022 04:29 PM · Technology | Consumer Staples | Healthcare

Riyue Co., Ltd. "construction project of finishing production line for key components of large offshore wind power with an annual output of 120000 tons" is planned to be postponed

Healthcare

HealthGuard: Registration of Indonesian Subsidiary, Investment in Producing HPV Vaccine

Jun 20, 2024 03:12 PM

Healthcare

SINOVAC Plans to Invest USD 100 Mn in Brazil Starting This Year

EqualOcean has learned that on June 4, Vice President of the Federative Republic of Brazil and Minister of Development, Industry, Trade, and Services, Geraldo Alckmin, met with SINOVAC(科兴) Chairman, President, and CEO Yin Weidong(尹卫东) in Beijing.

Jun 06, 2024 06:18 PM

Briefing Dec 06, 2021 03:39 PM · Technology | Healthcare

Hengrui medicine: a number of drugs have been approved to carry out clinical trials

Briefing Dec 03, 2021 03:59 PM · Technology | Consumer Staples | Healthcare

Alex: vometinib mesylate tablets are newly included in the national medical insurance catalogue

Briefing Nov 19, 2021 03:49 PM · Technology | Consumer Staples | Healthcare

Humanwell pharmaceutical: it is proposed to transfer 2.52% shares of Huatai Insurance with RMB 1.026 billion

Healthcare

Yilite Technology Completes A+ Round Financing of CNY 100 Million

Yilite Technology has secured over CNY 100 million in two rounds of financing within the year.

May 15, 2024 03:21 PM

Healthcare

Cellatopia Secures Nearly CNY Ten Mn in Seed Funding

EqualOcean has learned that Cellatopia(喜同生物), a biotechnology company based in Suzhou, recently announced the successful securing of nearly CNY ten million in seed funding. The funding was primarily led by Suzhou Shishangbai Venture Capital(苏州石上柏创业合伙企业) and followed by institutions such as Suzhou Nuowei Venture Investment Limited(苏州诺为创业投资有限公司).

Apr 18, 2024 01:25 PM

Briefing Oct 18, 2021 01:06 AM · Consumer Staples | Financials

Three quarterly countdown institutions reward the bank sector configuration value

Briefing Oct 08, 2021 03:52 PM · Consumer Discretionary | Healthcare | Industrials

Daqin Railway: in September, the freight volume of Daqin Railway decreased by 1.45% year-on-year

Briefing Sep 27, 2021 03:49 PM · Technology | Healthcare | Financials

West Gate: normal production and stable operation have been restored recently

Briefing Sep 17, 2021 03:50 PM · Technology | Healthcare

Xiangjiang Holdings: it plans to repurchase shares with no more than 145 million yuan

EqualOcean Analysis